Exclusive and adjuvant radiotherapy in breast cancer patients with synchronous metastases.

ABSTRACT:

Background

Data from the Surveillance, Epidemiology, and End Results program and the European Concerted Action on survival and Care of Cancer Patients (EUROCARE) project indicate that about 6% of women newly diagnosed with breast cancer have stage IV disease, representing about 12 600 new cases per year in the United States in 2005. Historically, local therapy of the primary tumor in this setting has been aimed solely at symptom palliation. However, several studies suggest that surgical excision of the primary tumor can prolong these patients' survival.

Discussion

Exclusive locoregional radiotherapy is an alternative form of locoregional treatment in this setting and may represent an effective alternative to surgery in this setting. Here we discuss current issues regarding e

SUBMITTER: Le Scodan R 

PROVIDER: S-EPMC2993682 | biostudies-literature | 2010 Nov

REPOSITORIES: biostudies-literature